文献速递烧伤创面修复

酶性清创后创面评估与治疗决策的评分者间信度及经验影响

Enzymatic Debridement for Burn Wound Care: Interrater Reliability and Impact of Experience in Post-intervention Therapy Decision.
PubMed 文献 · J Burn Care Res · 2021-01-01

该研究通过视频问卷调查31名来自11个烧伤中心的医师,评估酶性清创后创面床评估与治疗决策的评分者间信度及经验影响。结果显示总体共识率在创面评估为20%、治疗决策为40%,Krippendorff's alpha分别为0.32和0.31。高经验医师共识率显著高于中等经验者,视频分析被认为是有价值的评估与培训工具。

要点

  • 酶性清创后创面评估与治疗决策的评分者间信度较低,总体共识率分别为20%和40%。
  • 视频分析被90.3%的参与者认为可行、93.5%认为有益,100%认为可用于培训。

核心结论

  • 酶性清创后创面床评估和治疗决策的可靠性取决于评分医师的经验。
  • 视频分析被认为是酶性清创评估、决策和用户培训的有价值工具。

研究设计与样本

  • 基于视频的问卷调查,纳入来自11个烧伤中心的31名医师。
  • 参与者按酶性清创应用经验分为<10、10-19、20-49和≥50次应用四个亚组。
  • 展示15例混合模式至全层烧伤患者去除酶复合物后的视频,要求评估出血模式和治疗决策。

主要发现

  • 酶性清创后创面床评估的总体共识率(原始一致率≥80%)为20%,治疗决策为40%。
  • 创面床评估的Krippendorff's alpha为0.32(95%CI:0.15,0.49),治疗决策为0.31(95%CI:0.16,0.47)。
  • 90.3%的参与者认为视频分析可行,93.5%认为有益,100%认为对培训有用。

关键数值与推荐

  • 评分者间信度以原始一致率≥80%视为共识,并通过Krippendorff's alpha计算。
  • 经验分层依据酶性清创应用次数:<10、10-19、20-49、≥50次。

临床怎么用

  • 酶性清创后创面评估和治疗决策主观性强,低年资医师决策一致性低,需加强培训。
  • 视频分析可作为酶性清创后评估、决策支持和培训的辅助工具。

局限性

  • 研究为视频问卷调查,非真实临床场景,可能影响外部有效性。
  • 样本量较小(31名医师),来自11个烧伤中心,结果推广需谨慎。
  • 未报告视频评估与实际临床病程比较的具体结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Enzymatic debridement (ED) has become a reliable tool for eschar removal. Although ED application is simple, wound bed evaluation and therapy decision post-intervention are prone to subjectivity and failure. Experience in ED might be the key, but this has not been proven yet. The aim of this study was to assess interrater reliability (IR) in post-intervention wound bed evaluation and therapy decision as well as the impact of experience. In addition, the authors introduce video assessment as a valuable tool for post-ED decision-making and education. A video-based survey was conducted among physicians with various experiences in ED. The survey involved multiple-choice and 5-point Likert scale questions about professional status, experience in ED, confidence in post-ED wound bed evaluation, and therapy decision. Subsequently, videos of 15 mixed pattern to full-thickness burns immediately after removal of the enzyme complex were demonstrated. Participants were asked for evaluation of each burn wound, including bleeding pattern and consequent therapy decision. IR ≥ 80% was considered as a consensus. Responses were stratified according to participants' experience in applying ED (<10, 10-19, 20-49, and ≥50 applications). IR was assessed by chi-square test (raw agreement [RA]; ≥80% was considered as a consensus) and by calculation of Krippendorff's alpha. In addition, expert consensus for therapy decision was compared with the actual clinical course of each shown patient. Last, participants were asked for their opinion on video as an assessment tool for post-ED wound bed evaluation, decision-making, and training. Thirty-one physicians from 11 burn centers participated in the survey. The overall consensus (raw agreement [RA] ≥ 80%) in post-ED wound bed evaluation and therapy decision was achieved in 20 and 40%, respectively. Krippendorff's alpha is given by 0.32 (95% confidence interval: 0.15, 0.49) and 0.31 (95% confidence interval: 0.16, 0.47), respectively. Subgroup analysis revealed that physicians with high experience in ED achieved significantly more consensus in post-intervention wound bed evaluation and therapy decision compared with physicians with moderate experience (60 vs 13.3%; P = .02 and 86.7 vs 33.3%; P = .04, respectively). Video analysis was considered a feasible (90.3%) and beneficial (93.5%) tool for post-intervention wound bed evaluation and therapy decision as well as useful for training purposes (100%). Reliability of wound bed evaluation and therapy decision after ED depends on the experience of the rating physician. Video analysis is deemed to be a valuable tool for ED evaluation, decision-making, and user training.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Siegwart LC, Böcker AH, Diehm YF, et al. Enzymatic Debridement for Burn Wound Care: Interrater Reliability and Impact of Experience in Post-intervention Therapy Decision. J Burn Care Res. 2021. PMID: 33378534. doi:10.1093/jbcr/iraa218

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。